CompuGroup Medical SE & C... (CMPVF)
Compu Medical SE & KGaA Statistics
Share Statistics
Compu Medical SE & KGaA has 51.73M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 51.73M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | n/a |
FTD / Avg. Volume | n/a |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 26.04 and the forward PE ratio is null. Compu Medical SE & KGaA's PEG ratio is -0.84.
PE Ratio | 26.04 |
Forward PE | n/a |
PS Ratio | 0.78 |
Forward PS | n/a |
PB Ratio | 1.39 |
P/FCF Ratio | 13.72 |
PEG Ratio | -0.84 |
Enterprise Valuation
Compu Medical SE & KGaA has an Enterprise Value (EV) of 1.67B.
EV / Sales | 1.45 |
EV / EBITDA | 8.09 |
EV / EBIT | 12.99 |
EV / FCF | 25.49 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 1.36.
Current Ratio | 1.19 |
Quick Ratio | 1.15 |
Debt / Equity | 1.36 |
Debt / EBITDA | 4.25 |
Debt / FCF | 13.4 |
Interest Coverage | 3.17 |
Financial Efficiency
Return on Equity is 5.34% and Return on Invested Capital is 3.52%.
Return on Equity | 5.34% |
Return on Assets | 1.76% |
Return on Invested Capital | 3.52% |
Revenue Per Employee | $130,911.74 |
Profits Per Employee | $3,925.13 |
Employee Count | 8,815 |
Asset Turnover | 0.59 |
Inventory Turnover | 12.84 |
Taxes
Income Tax | 27.13M |
Effective Tax Rate | 43.84% |
Stock Price Statistics
The stock price has increased by -20.21% in the last 52 weeks. The beta is 0.9, so Compu Medical SE & KGaA's price volatility has been higher than the market average.
Beta | 0.9 |
52-Week Price Change | -20.21% |
50-Day Moving Average | 23.85 |
200-Day Moving Average | 22.79 |
Relative Strength Index (RSI) | 75.83 |
Average Volume (20 Days) | 6 |
Income Statement
In the last 12 months, Compu Medical SE & KGaA had revenue of 1.15B and earned 34.6M in profits. Earnings per share was 0.67.
Revenue | 1.15B |
Gross Profit | 965.14M |
Operating Income | 105.74M |
Net Income | 34.6M |
EBITDA | 206.9M |
EBIT | 95.25M |
Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 107.18M in cash and 879.99M in debt, giving a net cash position of -772.81M.
Cash & Cash Equivalents | 107.18M |
Total Debt | 879.99M |
Net Cash | -772.81M |
Retained Earnings | n/a |
Total Assets | 1.97B |
Working Capital | 63.35M |
Cash Flow
In the last 12 months, operating cash flow was 128.88M and capital expenditures -63.23M, giving a free cash flow of 65.66M.
Operating Cash Flow | 128.88M |
Capital Expenditures | -63.23M |
Free Cash Flow | 65.66M |
FCF Per Share | 1.27 |
Margins
Gross margin is 83.64%, with operating and profit margins of 9.16% and 3%.
Gross Margin | 83.64% |
Operating Margin | 9.16% |
Pretax Margin | 5.36% |
Profit Margin | 3% |
EBITDA Margin | 17.93% |
EBIT Margin | 9.16% |
FCF Margin | 5.69% |
Dividends & Yields
CMPVF pays an annual dividend of $1.08, which amounts to a dividend yield of 3.62%.
Dividend Per Share | $1.08 |
Dividend Yield | 3.62% |
Dividend Growth (YoY) | 100.81% |
Payout Ratio | 144.18% |
Earnings Yield | 3.84% |
FCF Yield | 7.29% |
Analyst Forecast
Currently there are no analyst rating for CMPVF.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 1.37 |
Piotroski F-Score | 7 |